Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Intrathecal morphine for pain control after major laparoscopic abdominal surgery

Official title: Intrathecal Morphine for Postoperative Analgesia in Major Laparoscopic Abdominal Surgery (IMPACT-Scope): a Randomised, Sham-controlled, Blinded, Multicentre Clinical Trial

Run by First Affiliated Hospital, Sun Yat-Sen University · NCT06666985 · Data updated 2026-11-12

This trial will test whether adding a single intrathecal morphine injection to usual care improves early recovery and pain for adults having major laparoscopic abdominal surgery.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment700 (estimated)
SponsorFirst Affiliated Hospital, Sun Yat-Sen University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedDecember 16, 2024
Main results expectedSeptember 2026
Study endsOctober 2026
Registry record updatedAugust 28, 2026
Trial IDNCT06666985 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older scheduled for elective major laparoscopic or robotic abdominal surgery (colorectal, gynaecology, hepato-biliary, upper GI, or urology) with expected surgery duration ≥2 hours and anticipated hospital stay ≥24 hours who can give informed consent.

Probably not a fit

Patients with contraindications to intrathecal injection, coagulopathy, allergy to study drugs, cognitive impairment preventing questionnaire completion, or those likely to require postoperative invasive ventilation are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind, sham-controlled Phase 4 trial compares a single-dose intrathecal morphine plus usual care versus a sham intrathecal procedure plus usual care in adults undergoing elective major laparoscopic or robotic abdominal surgery. Participants are randomized on the day of surgery and outcome assessors collect data on the day of surgery and postoperative day 1, including the 15-item Quality of Recovery (QoR-15) score. The primary goal is to detect a clinically meaningful improvement of at least 6 points on QoR-15 at postoperative day 1. Safety monitoring includes surveillance for opioid-related adverse events such as respiratory depression and hemodynamic instability.

Why it matters

Potential benefit: If successful, adding intrathecal morphine could improve early postoperative recovery and pain control while reducing systemic opioid requirements.

How similar studies have gone: Prior studies of intrathecal morphine in abdominal and other surgical settings have often shown improved analgesia and opioid-sparing effects, but high-quality sham-controlled evidence specifically in major laparoscopic surgery is limited and safety concerns like respiratory depression remain.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Age 18 years or over AND able to give informed consent (with interpreters provided where necessary)
* Elective (i.e., planned) laparoscopic or robotic abdominal surgery within one or more of the following specialties:

  * Colorectal
  * Gynaecology
  * Hepato-biliary (including pancreatic surgery)
  * Upper gastrointestinal
  * Urology/Renal
* Anticipated duration of surgery ≥ 2 hours (from knife-to-skin to end of wound closure)
* Anticipated hospital stay ≥ 24 hours (from the end of surgery)

Exclusion criteria:

* Allergy to study drugs
* Anatomical factors making intrathecal injection impossible
* Anticipated requirement for postoperative invasive ventilation
* American Society of Anesthesiologists (ASA) Score \<IV
* Coagulopathies (i.e. INR\>1.3 and/or platelet count\<100×10\^9/L)
* Cognitive impairment leading to inability to complete the study processes and questionnaires
* Drugs affecting coagulation (except aspirin), which have not been suitably and timely paused preoperatively
* Infection near the planned site of intrathecal injection
* Ongoing sepsis
* Patients previously included in the trial and who need to return to theatre for a new abdominal surgery
* Pregnancy or breast feeding

Where it's running

  • The First Affiliated Hospital of Sun Yat-sen University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.